Enteric plexus neuropathy associated with PD-L1 blockade in a patient with small-cell lung cancer

Ioannis P Trontzas1, Vasiliki E Rapti1, Nikolaos K Syrigos1

  • 13rd Department of Internal Medicine, Oncology Unit, Sotiria General Hospital, Athens School of Medicine, 11527, Greece.

Immunotherapy
|July 12, 2021
PubMed

Insights

Immune checkpoint inhibitors can cause rare, severe nervous system side effects. This case highlights a potentially fatal intestinal issue from PD-L1 blockade in lung cancer patients.

Area of Science:

  • Oncology
  • Neuroimmunology
  • Gastroenterology

Background:

  • Immune checkpoint inhibitors (ICIs) have transformed cancer treatment.
  • Increasing ICI use reveals diverse, potentially severe immune-related adverse events (irAEs).
  • Nervous system irAEs are uncommon but critical to recognize.

Observation:

  • Immune-related autonomic neuropathy presents with varied symptoms, including gastrointestinal and cardiovascular issues.
  • Intestinal pseudo-obstruction due to immune-related myenteric autonomic neuropathy is under-recognized.
  • A unique case of enteric plexus neuropathy induced by PD-L1 blockade is presented.

Findings:

  • PD-L1 blockade can induce enteric plexus neuropathy, leading to intestinal pseudo-obstruction.
  • This rare irAE is potentially fatal if not promptly identified and managed.
  • Early diagnosis and intervention are crucial for patient outcomes.

Implications:

  • Clinicians should consider enteric plexus neuropathy in patients on PD-L1 inhibitors presenting with gastrointestinal dysmotility.
  • Further research is needed to understand the mechanisms and optimal management of ICI-induced autonomic neuropathies.
  • This case underscores the importance of vigilance for rare irAEs in the evolving landscape of cancer immunotherapy.

Related Concept Videos

Nerve Supply of the GI Tract01:27

Nerve Supply of the GI Tract

The neuronal supply to the gastrointestinal (GI) tract is essential for regulating various functions, including digestion, absorption, and movement of food. This intricate network of nerves is known as the enteric nervous system (ENS), often referred to as the "second brain" of the body.
The enteric nervous system consists of two major plexuses: the myenteric plexus (Auerbach's plexus) and the submucosal plexus (Meissner's plexus). These plexuses are located within the layers of...
2.1K
Spinal Nerves: Plexus I01:22

Spinal Nerves: Plexus I

Nerve plexuses are networks of interlacing nerves that serve as communication hubs to distribute and organize nerve action across various body regions. The nerve plexuses are organized into the cervical plexus located in the neck region, brachial plexus in the shoulder area, lumbar plexus found in the lower back, sacral plexus situated in the pelvis, and coccygeal plexus located in the coccygeal region.
The Cervical Plexus
The cervical plexus, formed by the anterior rami of the first four...
1.6K
Spinal Nerves: Plexus II01:21

Spinal Nerves: Plexus II

The plexuses of the lower body include the lumbar, sacral, and coccygeal plexuses, which innervate the abdomen, pelvis, legs, and coccygeal region. These plexuses control the transmission of sensory information and coordinate motor functions of the lower body.
The Lumbar Plexus
The lumbar plexus is situated within the lumbar region of the back and is primarily formed by the first four lumbar spinal nerves (L1 to L4). This plexus extends its branches into several nerves, including the...
1.2K
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.7K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
316